SCHEMBL15744122

SCHEMBL15744122

Cc1sc(C(N)=O)c(-c2ccc(Cl)cc2Cl)c1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.47
GSK3A P49840 1/20 0.47
DYRK1A Q13627 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
KDM4E B2RXH2 4/20 0.44
CDC7 O00311 2/20 0.42
CCNE1 P24864 2/20 0.42
CDK2 P24941 2/20 0.42
DBF4 Q9UBU7 2/20 0.42
PIK3CA P42336 1/20 0.42
BRAF P15056 1/20 0.41
GABRA1 P14867 3/20 0.40
GABRG2 P18507 3/20 0.40
GABRB3 P28472 3/20 0.40
GABRB2 P47870 2/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953790 0.85 GSK3B (0.44) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL13256754 0.85 GSK3B (0.44) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL953956 0.85 GSK3B (0.44) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL1551828 0.83 GRIA2 (0.44) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL12947578 0.79 CDC7 (0.55) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL7998235 0.78 PIK3CA (0.53) GSK3BGSK3ADYRK1ACLK4KDM4E
SCHEMBL1551287 0.77 PIK3CA (0.74) PIK3CAHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL12947611 0.76 CDC7 (0.44) GSK3BGSK3ADYRK1ACLK4CDC7
SCHEMBL13105879 0.76 GSK3B (0.42) GSK3BGSK3ADYRK1ACLK4CDC7
SCHEMBL951777 0.75 CDC7 (0.44) GSK3BGSK3ADYRK1ACLK4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2313399-B1 THIOPHENE OR THIAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS MILLENNIUM PHARM INC (US) 2014-05-28 EP disclosed